Shah Amy S, Barrientos-Pérez Margarita, Chang Nancy, Fu Jun-Fen, Hannon Tamara S, Kelsey Megan, Peña Alexia S, Pinhas-Hamiel Orit, Urakami Tatsuhiko, Wicklow Brandy, Wong Jencia, Mahmud Farid H
Division of Endocrinology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, Ohio, USA.
Division of Clinical Research, Hospital Ángeles Puebla, Puebla, Mexico.
Horm Res Paediatr. 2024;97(6):555-583. doi: 10.1159/000543033. Epub 2024 Dec 14.
Youth-onset type 2 diabetes (T2D) results from genetic, environmental, and metabolic causes that differ among individuals and populations. This chapter builds on the 2022 ISPAD guidelines and summarizes recent advances in the management of T2D in children and adolescents. Updates include diagnostic algorithm for youth with new onset T2D, algorithms and tables for treatment, management, and assessment of comorbidities and complications and recommendations on recently approved pharmacologic therapies for the treatment of youth-onset T2D and management strategies. Youth-onset type 2 diabetes (T2D) results from genetic, environmental, and metabolic causes that differ among individuals and populations. This chapter builds on the 2022 ISPAD guidelines and summarizes recent advances in the management of T2D in children and adolescents. Updates include diagnostic algorithm for youth with new onset T2D, algorithms and tables for treatment, management, and assessment of comorbidities and complications and recommendations on recently approved pharmacologic therapies for the treatment of youth-onset T2D and management strategies.
青少年起病的2型糖尿病(T2D)由个体和人群中不同的遗传、环境及代谢因素引起。本章以2022年国际儿童青少年糖尿病学会(ISPAD)指南为基础,总结了儿童和青少年T2D管理方面的最新进展。更新内容包括新发T2D青少年的诊断算法、治疗算法及表格、合并症和并发症的管理与评估,以及关于最近批准的治疗青少年起病T2D的药物疗法和管理策略的建议。青少年起病的2型糖尿病(T2D)由个体和人群中不同的遗传、环境及代谢因素引起。本章以2022年国际儿童青少年糖尿病学会(ISPAD)指南为基础,总结了儿童和青少年T2D管理方面的最新进展。更新内容包括新发T2D青少年的诊断算法、治疗算法及表格、合并症和并发症的管理与评估,以及关于最近批准的治疗青少年起病T2D的药物疗法和管理策略的建议。